N-ras and p53 gene mutations in Japanese patients with myeloproliferative disorders

American Journal of Hematology

Volumn 71, Issue 2, 2002, Pages 131-133

  Tsurumi, Shigeharu ^a   Nakamura, Yuichi ^a   Maki, Kazuhiro ^a   Omine, Mitsuhiro ^b   Fujita, Kazuhiro ^b   Okamura, Takashi ^c   Niho, Yoshiyuki ^d   Hashimoto, Sachiko ^e   Kanno, Keiko ^e   Suzuki, Kenshi ^e   Hangaishi, Akira ^f   Ogawa, Seishi ^f   Hirai, Hisamaru ^f   Mitani, Kinuko ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d CHIHAYA HOSPITAL   (Japan)

^e JAPANESE RED CROSS MEDICAL CENTER   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

Author keywords

Essential thrombocythemia; Gene mutation; Myeloproliferative disorder; N ras; P53; Polycythemia vera

Indexed keywords

PROTEIN P53;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BONE MARROW CELL; CHRONIC GRANULOCYTIC LEUKEMIA; CLINICAL ARTICLE; EXON; FEMALE; GENE; GENE DELETION; GENE DISRUPTION; HUMAN; IDIOPATHIC DISEASE; JAPAN; MALE; MISSENSE MUTATION; MYELOFIBROSIS; MYELOPROLIFERATIVE DISORDER; ONCOGENE N RAS; POLYCYTHEMIA VERA; PRIORITY JOURNAL; THROMBOCYTHEMIA; TUMOR SUPPRESSOR GENE;

ADULT; AGED; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, RAS; HUMANS; JAPAN; MALE; MIDDLE AGED; MUTATION; MYELOPROLIFERATIVE DISORDERS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036785106     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.10188     Document Type: Article

References (13)

1. Cervantes F, Tassies D, Salgado C, Rovira M, Pereira A, Rozman C. Acute transformation in nonleukemic myeloproliferative disorders: actuarial probability and main characteristics in a series of 218 patients. Acta Hematol 1991;85:124-127.
2. Gaidano G, Guerrasio A, Serra A, Carozzi F, Cambrin GR, Petroni D, Saglio G. Mutations in the P53 and RAS family genes are associated with tumor progression of BCR/ABL negative chronic myeloproliferative disorders. Leukemia 1993;7:946-953.
3. Gaidano G, Pastore C, Santini V, Nomdedeu J, Gamberi B, Capello D, Vischia F, Resegotti L, Mazza U, Ferrini PR, Lo Coco F, Saglio G. Genetic lesions associated with blastic transformation of polycythemia vera and essential thrombocythemia. Genes Chromosomes Cancer 1997;19:250-255.
4. Sterkers Y, Preudhomme C, Lai J-L, Demory J-L, Caulier M-T, Wattel E, Bordessoule D, Bauters F, Fenaux P. Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion. Blood 1998;91:616-622.
5. Berlin N. Diagnosis and classification of the polycythemias. Semin Hematol 1975;12:339-351.
6. Murphy S, Iland H, Rosenthal D, Laszlo J. Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group. Semin Hematol 1986;23:117-182.
7. Okamura T, Kinukawa N, Niho Y, Mizoguchi H. Primary chronic myelofibrosis: clinical and prognostic evaluation in 336 Japanese patients. Int J Hematol 2001;73:194-198.
8. Mitani K, Hangaishi A, Imamura N, Miyagawa K, Ogawa S, Kanda Y, Yazaki Y, Hirai H. No concomitant occurrence of the N-ras and p53 gene mutations in myelodysplastic syndromes. Leukemia 1997;11:863-865.
9. Higuchi T, Oba R, Endo M, Harada H, Mori H, Niikura H, Omine M, Fujita K. Transition of polycythemia vera to chronic neutrophilic leukemia. Leuk Lymphoma 1999;33:203-206.
10. Horikoshi M, Machida U, Itikawa M, Seo S, Masuda S, Kurokawa M, Ogawa S, Sunaga S, Honda H, Aoki K, Chiba S, Mitani K, Hirai H, Yazaki Y. Essential thrombocythemia in transformation from myelodysplastic syndrome to acute myeloid leukemia with inv(3) after treatment for gastric cancer. Jpn J Clin Hematol 2000;41:68-71.
11. Janssen JWG, Steenvoorden ACM, Lyons J, Anger B, Bohlke JU, Bos JL, Seliger H, Bartram CR. RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferafive disorders, and myelodysplastic syndromes. Proc Natl Acad Sci USA 1987;84:9228-9232.
12. Reilly JT, Wilson G, Barnett D, Watmore A, Potter A. Karyotypic and ras gene mutational analysis in idiopathic myelofibrosis. Br J Haematol 1994;88:575-581.
13. Buschle M, Janssen JW, Drexler H, Lyons J, Anger B, Bartram CR. Evidence for pluripotent stem cell origin of idiopathic myelofibrosis: clonal analysis of a case characterized by a N-ras gene mutation. Leukemia 1988;2:658-660.